Characterization of liver injury induced by a pyrrolizidine alkaloid in rats.

Abstract

BACKGROUND:

Pyrrolizidine alkaloids (PAs) are common phytotoxins. PA intoxication is reported to cause severe acute liver damage, typically known as hepatic sinusoidal obstruction syndrome (HSOS), but it remains obscure whether the acute liver damage may progress into chronic liver disease characterized by hepatic fibrosis.

PURPOSE:

This study aims to characterize the biochemical markers of liver injury and histological features of regressive and progressive liver fibrosis, and to examine changes in hepatic gene expression that may underpin mechanisms of fibrogenesis in rats induced by retrorsine (RTS), a representative toxic PA.

STUDY DESIGN/METHODS:

Rats were gavaged with RTS via two dosing regimens, i.e. a single dose of 40 mg/kg (Group 1) and two doses of 40 mg/kg and 20 mg/kg on day 0 and day 7 (Group 2), respectively. Rats receiving one (Group 3) or two (Group 4) doses of vehicle served as negative controls. The animals were followed for up to 16 weeks by serum biochemical analyses and histological examination, and gene expression assays of liver tissues.

RESULTS:

Acute liver injury on day 2 manifested as HSOS, characterized by sinusoidal dilation, endothelial cell damage, and elevated serum alanine aminotransferase activity and bilirubin levels. In Group 1, mild liver fibrosis developed at sinusoids and perisinusoidal space surrounding the central veins at week 1 and 2, and thereafter, all liver injury resolved gradually. In Group 2, liver fibrosis progressed within the 16-week observation period. No apparent liver injury was observed in Groups 3 and 4. Compared with negative control groups, RTS induced myofibroblastic activation, TGF-β1 signaling, and changes in expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1). These dynamic changes differed in Groups 1 and 2, corresponding with the regression and progression of liver fibrosis, respectively, in these groups.

CONCLUSION:

This study has provided in-vivo proof of concept that "one hit" and "two hits" of RTS lead to acute resolving liver injury and chronic progressive liver fibrosis, respectively. These animal models may serve as powerful tools for studying RTS toxicology and related preventive and therapeutic strategies and as positive controls for studying other PA- and non-PA-induced liver injury.

• Authors: Xinmeng Chen, Jiang Ma, Yisheng He, Junyi Xue, Zijing Song, Qihe Xu, Ge Lin
• Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 89 Pg. 153595 (Aug 2021) ISSN: 1618-095X [Electronic] Germany
• PMID: 34153877 (Publication Type: Journal Article)
• Copyright: Copyright © 2021. Published by Elsevier GmbH.

Chemical References

• Pyrrolizidine Alkaloids
• Tgfb1 protein, rat
• Tissue Inhibitor of Metalloproteinase-1
• Transforming Growth Factor beta1
• Matrix Metalloproteinase 9
• Mmp9 protein, rat

Topics

• Animals
• Chemical and Drug Induced Liver Injury (pathology)
• Hepatic Veno-Occlusive Disease (chemically induced, pathology)
• Liver (pathology)
• Liver Cirrhosis (chemically induced, pathology)
• Matrix Metalloproteinase 9
• Pyrrolizidine Alkaloids (toxicity)
• Rats
• Tissue Inhibitor of Metalloproteinase-1
• Transforming Growth Factor beta1